Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy of combined use of intraarticular and intravenous tranexamic acid in total knee arthroplasty.

Literature DB >> 26046086

Efficacy of combined use of intraarticular and intravenous tranexamic acid in total knee arthroplasty.

Daniel R Whiting¹, Rafael J Sierra¹.

Abstract

Entities: Chemical

Year: 2015 PMID： 26046086 PMCID： PMC4437937 DOI： 10.3978/j.issn.2305-5839.2015.03.37

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

24 in total

1. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.

Authors: Jeremiah R Brown; Nancy J O Birkmeyer; Gerald T O'Connor
Journal: Circulation Date: 2007-05-28 Impact factor: 29.690

2. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.

Authors: Jean Wong; Amir Abrishami; Hossam El Beheiry; Nizar N Mahomed; J Roderick Davey; Rajiv Gandhi; Khalid A Syed; Syed Muhammad Ovais Hasan; Yoshani De Silva; Frances Chung
Journal: J Bone Joint Surg Am Date: 2010-11-03 Impact factor: 5.284

3. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.

Authors: Jay N Patel; Jonathon M Spanyer; Langan S Smith; Jiapeng Huang; Madhusudhan R Yakkanti; Arthur L Malkani
Journal: J Arthroplasty Date: 2014-03-21 Impact factor: 4.757

4. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).

Authors: Paula M Bokesch; Gabor Szabo; Ryszard Wojdyga; Hilary P Grocott; Peter K Smith; C David Mazer; Santosh Vetticaden; Alistair Wheeler; Jerrold H Levy
Journal: J Thorac Cardiovasc Surg Date: 2011-07-02 Impact factor: 5.209

Efficacy of combined use of intraarticular and intravenous tranexamic acid in total knee arthroplasty.

1. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.

2. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.

3. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.

4. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).

5. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee.

6. Tranexamic acid and fibrinolytic activity of the vessel wall.

7. Acute renal failure secondary to antifibrinolytic therapy.

8. Tranexamic acid and arterial thrombosis.

9. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty.

Review 10. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis.

1. Platelet-rich plasma for the reduction of blood loss after total knee arthroplasty: a clinical trial.